Tuesday, 02 January 2024 12:17 GMT

Plasma Fractionation Market Leading Growth Drivers, Regional Analysis, And Industry Insights


(MENAFN- EIN Presswire)

Plasma Fractionation Market

The growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

PORTLAND, OREGON, US, August 1, 2022 /EINPresswire.com / -- Plasma fractionation is a separation technique, which is employed to obtain plasma derivatives. There are different types of a plasma derivatives available in the market. These include albumin and immunoglobulins. These products contain concentrated fractions of plasma protein, which is obtained by fractionation of plasma collected from a large number of donors.

The growth of the Plasma fractionation market is driven by demand for plasma fractionation products is on the rise, owing to surge in prevalence of various medical conditions that require use of plasma derivatives such as hemophilia. Furthermore, surge in adoption of plasma derivatives across the globe is another major factor that contributes to growth of the market.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :
โ€ขBaxter International Inc.,
โ€ขBio product laboratory,
โ€ขBiotest AG,
โ€ขCSL Ltd.,
โ€ขGrifols SA,
โ€ขKedrion S.P.A (Kedrion Biopharma Inc.),
โ€ขLFB S. A.,
โ€ขOctapharma AG,
โ€ขSanquin Blood Supply Foundation,
โ€ขTakeda Pharmaceutical Company Limited.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

๐†๐ž๐ญ ๐”๐ฉ ๐“๐จ ๐Ÿ๐ŸŽ% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ, ๐“๐ข๐ฅ๐ฅ ๐ญ๐ก๐ž ๐ƒ๐š๐ญ๐ž ๐Ÿ๐ŸŽ๐ญ๐ก ๐จ๐Ÿ ๐€๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ

Surge in geriatric population across the globe, which is predisposed to various rare diseases that require use of plasma derivatives is the major factor that propels the market growth. Moreover, rise in use of immunoglobulins and alpha-1-antitrypsin in areas of medicine worldwide also fuels growth of the plasma fractionation market. Furthermore, surge in plasma collection centers worldwide is another major factor that contributes toward the growth of the market. In addition, favorable government support to spread awareness related to use of plasma derived products boost the growth of the plasma fractionation market.

However, high cost of plasma derived products restricts the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

The global plasma fractionation market is segmented on the basis of product, sector, and country. On the basis of product, the market is divided into albumin, immunoglobulins, coagulation factor VIII and coagulation factor IX. On the basis of sector, the market is divided into private sector and public sector. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ@

๐Š๐ž๐ฒ ๐…๐ข๐ง๐๐ข๐ง๐ ๐ฌ
โ€ขIn terms of value, by product, the immunoglobulin segment accounted for more than half share in the plasma fractionation market in 2019.
โ€ขIn terms of value, by region, the Asia-Pacific is anticipated to grow with the highest CAGR of 6.6% throughout the forecast period.
โ€ขAsia-Pacific accounted for more than half share in the global plasma fractionation market in terms of volume for albumin & immunoglobulin in 2019.
โ€ขEurope accounted for more than one fourth share of the global plasma fractionation market in terms of volume for coagulation factor VIII & coagulation factor IX, in 2019.

๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ@

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
Actinic Keratosis Treatment Market
Retail Clinics Market


๐–๐ž ๐š๐ฅ๐ฌ๐จ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ฌ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐š๐ง๐ ๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ
โ€ข North America Plasma Fractionation Market
โ€ข Japan Plasma Fractionation Market
โ€ข South Korea Plasma Fractionation Market
โ€ข Singapore Plasma Fractionation Market
โ€ข Australia Plasma Fractionation Market
โ€ข Europe Plasma Fractionation Market

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality ofโ€œMarket Research Reportsโ€ andโ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN02082022003118003196ID1104630117



EIN Presswire

Legal Disclaimer:
MENAFN provides the information โ€œas isโ€ without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search